Bio Path Holdings Shares up 14.6% as Experimental Cancer Drugs Show Promise in Ongoing Trials
Bio Path Holdings股票上漲14.6%,因爲實驗性抗癌藥物在進行中的試驗中顯示出了希望
Bio Path Holdings Shares up 14.6% as Experimental Cancer Drugs Show Promise in Ongoing Trials
Bio Path Holdings股票上漲14.6%,因爲實驗性抗癌藥物在進行中的試驗中顯示出了希望
譯文內容由第三人軟體翻譯。